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Abstract
NKG2D plays a major role in controlling immune responses through the regulation of natural killer (NK) cells, ab and cd T-
cell function. This activating receptor recognizes eight distinct ligands (the MHC Class I polypeptide-related sequences (MIC)
A andB, and UL16-binding proteins (ULBP)1–6) induced by cellular stress to promote recognition cells perturbed by
malignant transformation or microbial infection. Studies into human cytomegalovirus (HCMV) have aided both the
identification and characterization of NKG2D ligands (NKG2DLs). HCMV immediate early (IE) gene up regulates NKGDLs, and
we now describe the differential activation of ULBP2 and MICA/B by IE1 and IE2 respectively. Despite activation by IE
functions, HCMV effectively suppressed cell surface expression of NKGDLs through both the early and late phases of
infection. The immune evasion functions UL16, UL142, and microRNA(miR)-UL112 are known to target NKG2DLs. While
infection with a UL16 deletion mutant caused the expected increase in MICB and ULBP2 cell surface expression, deletion of
UL142 did not have a similar impact on its target, MICA. We therefore performed a systematic screen of the viral genome to
search of addition functions that targeted MICA. US18 and US20 were identified as novel NK cell evasion functions capable
of acting independently to promote MICA degradation by lysosomal degradation. The most dramatic effect on MICA
expression was achieved when US18 and US20 acted in concert. US18 and US20 are the first members of the US12 gene
family to have been assigned a function. The US12 family has 10 members encoded sequentially through US12–US21; a
genetic arrangement, which is suggestive of an ‘accordion’ expansion of an ancestral gene in response to a selective
pressure. This expansion must have be an ancient event as the whole family is conserved across simian cytomegaloviruses
from old world monkeys. The evolutionary benefit bestowed by the combinatorial effect of US18 and US20 on MICA may
have contributed to sustaining the US12 gene family.
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Introduction
Human cytomegalovirus (HCMV) is a clinically important
pathogen, which is particularly associated with high levels of
morbidity and mortality in immuno-compromised individuals.
Systemic HCMV infection results in a higher incidence of graft
rejection in transplant recipients and a wide range of end-organ
disease including pneumonia, enteritis, hepatitis and retinitis
(specifically in HIV-AIDS). The virus is the major cause of
congenital birth defects, with long-term sequelae including mental
retardation and sensorineural hearing loss [1]. A correlation has
been established between infections and two common and
aggressive brain tumors (medulloblastoma and glioblastoma
multiforme) [2,3], which remains controversial [4], while HCMV
has also been implicated in cardiovascular disease, arthritis and in
imprinting characteristic changes on the immune repertoire
[2,5,6]. Nevertheless, the vast majority of HCMV primary
infections are subclinical and are followed by life-long asymptom-
atic persistence. Thus, while a competent immune response is
unable to eliminate this herpesvirus, in most individuals it is
effective at limiting virus replication and preventing disease.
HCMV has the largest genome (,236 kbp) of any character-
ized human virus and is a paradigm of viral immune evasion. A
substantial proportion of its coding capacity is dedicated to
evading or modulating immune defenses, and includes genes that
target the antigen presentation and processing pathway (US2,
US3, US6, US11, and miR US4-1) [7,8,9,10,11,12,13], human
leukocyte antigen (HLA)-G (US10) [14], T-cell receptor signaling
(UL11) [15], TNF-related apoptosis-inducing ligand (TRAIL)
death receptor signaling (UL141) [16], interferon signaling or its
downstream effects (UL83) [17,18,19] and dendritic cell cytokine
secretion (UL7) [20]. The virus also encodes interleukin-10
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(UL111A) [21] and interleukin-8 (UL146) homologs [22]. Natural
killer (NK) cells play a critical role in the control of HCMV
infections; individuals with genetic defects in their NK cell
response exhibit extreme susceptibility to the virus [23,24,25,26].
The prognosis of bone marrow and renal transplant patients
infected with HCMV infection has recently been demonstrated to
correlate with the genotype of specific NK cell receptors (KIR)
[27]. The significance of the NK cell response is also reflected in
the great lengths to which HCMV goes to evade it. To date,
UL16, UL18, UL40, UL83, UL141, UL142, and miR-UL112
have all been identified as NK cell evasion functions
[28,29,30,31,32,33,34,35,36,37,38,39,40].
NK cells constitute a heterogeneous population that express a
mosaic of inhibitory and activating receptors, each capable of
recognizing and responding to specific ligands presented by
potential target cells [41]. The activating receptor NKG2D is
remarkable in being expressed ubiquitously on all NK cells and
capable of recognizing at least 8 distinct ligands: the major
histocompatibility complex class I (MHC-I) chain-related mole-
cules (MICA and MICB) and the UL16-binding proteins 1–6
(ULBP1-ULBP6) [41,42,43]. NKG2D ligands (NKG2DL) can be
induced on the cell surface during times of cellular stress, including
genotoxic damage, growth stimulation or viral infection. Within
24 h post infection (p.i.), HCMV activates all NKG2DL with the
exception of ULBP4 [44]. More specifically, the HCMV major
immediate early (IE) proteins IE1 and IE2 (encoded by genes
UL123 and UL122, respectively) have been implicated in
activating transcription of the MICA/B promoters [45]. HCMV
counters this up regulation through (i) the sequestration of MICB,
ULBP1, ULBP2, and ULBP6 in the ER by the UL16 protein
[33,34,35,36,43,46], (ii) the retention of MICA and ULBP3 by the
UL142 protein within the cis-Golgi [32,47,48], and (iii) the
microRNA miRUL112 targeting the MICB transcript [28]. The
high degree of sequence polymorphism exhibited by both MICA
(80 alleles) and MICB (33 alleles) has the potential to provide an
added challenge to the virus. Indeed, it has been proposed that this
degree of MICA/B diversity may have been selected as a
mechanism by which cells evade HCMV infection [48].
We sought initially to explore whether the rapid kinetics of
NKG2DL expression during HCMV infection provides a window
of opportunity for NK cell recognition prior to the expression of
virus-encoded immune evasion proteins. In characterising the up
regulation of NKG2DL, we identified a differential effect on
MICA and MICB by the HCMV IE gene products, and yet
HCMV immune evasion functions were effective in preventing
surface expression of these NKG2DL through the early phase of
lytic infection. However, the full complement of HCMV immune
evasion functions targeting the NKG2DL had not been defined.
We now describe the identification and characterization of two
novel NK cell evasion genes, HCMV US18 and US20 act
individually and in concert to suppress expression cell surface
MICA. The US12 gene family comprise some 10 genes arranged
sequentially (US12-US21) and uninterrupted through a 9 kb
stretch if the US genomic region [49]. US18 and US20 are the first
members of this large gene family to be assigned a function.
Results
Differential regulation of NKG2DL by the HCMV major IE
genes
The regulation and function of NKG2DL exhibits the properties
of an intrinsic host immune defense system designed to sense cellular
changes associated with danger or pathogen-associated molecular
patterns. The existence of eight dedicated ligands provides great
scope for the NKG2D receptor to sense and react to a broad range
of stimuli. HCMV IE genes have previously been implicated in the
transcriptional activation of NKG2Ls [45,50]. Therefore, we first
examined the capacity of IE1 and IE2 to regulate the various
NKG2DL. When expressed using adenovirus (Ad) vectors, IE1
induced relatively modest increases in MICA and MICB, but
provided for a major up regulation in ULBP2 both at the level of
total protein expression and specifically on the cell surface (Fig. 1A
and B). In contrast, IE2 induced strong activation of MICA and
MICB, yet only a small increase ULBP2 levels. IE1 and IE2 were
thus found to differentially activate individual ligands recognized by
the NKG2D activating receptor. Consistent with their capacity to
up regulate NKG2DL, IE1 and IE2 were each able individually to
sensitize cells to NK cell-mediated cytotoxicity (Fig. 1C). We
concluded that the infected cell responds to differential sensing of
the expression of IE1 and IE2 by promoting the up regulation of
ULBP2 and MICA/B, respectively.
Additional HCMV functions implicated in regulating
MICA
We hypothesized that HCMV-infected cells may be vulnerable
to NK cell surveillance during the early phase if there were a
temporal window between the activation of NKG2Ls by IE1 and
IE2 and the expression of effective HCMV counter measure. To
investigate this possibility, the expression of MICA, MICB,
ULBP1, ULBP2 and ULBP3 was monitored throughout the
course of productive HCMV infection (Fig. 1D, Fig. S1, Fig. S2).
MHC Class-I (MHC-I) expression was included as an infection
control. At 6 h p.i., there was no difference between mock- and
virus-infected cells in MHC-I or NKG2DL expression. However,
cell surface down-regulation of MHC-I expression was clearly
observed through the early and late phases of a productive
replication cycle (24 to 120 h p.i). At no stage during the
replication cycle did HCMV infection induce an up regulation
MICA, MICB, or ULBP2 expression at the cell surface. Thus, we
were unable to detect the hypothesized temporal window during
which the infected cell may be vulnerable to NK cytotoxicity
through activation of NKG2D.
Author Summary
Human cytomegalovirus (HCMV) is a herpesvirus that
infects most people in the world, usually without
producing symptoms. However, infection is life-long and
must be kept in check by the immune system. When the
immune system is weakened, the outcome of HCMV
infection can be very serious. Thus, HCMV is the major
cause of birth defects resulting from infection of the fetus
during pregnancy, and it can cause severe disease in
people with a weakened immune system, especially
transplant recipients and HIV/AIDS patients. One type of
immune cell, the natural killer (NK) cell, is crucial in
controlling cells in the body that are abnormal. They do
this by recognizing cells, which have special stress proteins
on their surface, and killing them. When cells are infected
with HCMV, they start to make these stress proteins.
However, the virus has evolved ways to stop NK cells from
killing infected cells by quickly stopping the stress proteins
from reaching the surface. We have now identified two
HCMV genes that target a major stress protein (called
MICA) and cause its rapid destruction. Removing these two
genes from HCMV renders infected cells very susceptible
to killing by NK cells. This discovery might help the
development of new ways to fight HCMV.
HCMV Targets MICA for Lysosomal Degradation
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As the NKG2DLs must first respond to IE gene expression, they
should be activated with similar kinetics to those of a standard
HCMV-encoded early gene. To be effective, the corresponding
HCMV counter measure must therefore also be expressed with
early phase kinetics. UL16 is clearly essential during this process,
as its deletion (strain Merlin DUL16) increased cell surface MICB,
Figure 1. Regulation of NKG2DL during HCMV infection. A. Fibroblasts (HF-CARs) were infected with RAds expressing IE1 or IE2 at an m.o.i. of
1. Cell surface expression of MICA, MICB, MICA/B, and ULBP2 were analyzed by flow cytometry at 72 h p.i. The results shown are representative of 2
independent experiments. B. Fibroblasts were infected with RAds expressing IE1 or IE2 at an m.o.i. of 1–8 or RAd control (CTRL) moi 1. Expression of
MICA, MICB, MICA/B, and ULBP2 was analyzed by immunoblotting at 72 h p.i. The results shown are representative of 2 independent experiments. C.
Fibroblasts were infected with RAds expressing IE1 or IE2 or RAds lacking an insert (RAd-CTRL). Infected cells were used as targets for IFN-a treated NK
cells in a 51Cr release assay at an E:T ratio of 1:50. The results shown are representative of 2 independent experiments and were analyzed by 2-way
ANOVA (** p,0.01, *** p= 0.001). D. Fibroblasts (HF-TERTs) were mock-infected or infected with HCMV strain Merlin or deletion mutants of this strain
lacking UL16 (DUL16) or UL142 (DUL142). Cell surface expression of MICA, MICB, MICA/B, ULBP2, MHC-I, or murine immunoglobulin (mIgG) was
analyzed between 6 and 120 h p.i. by flow cytometry. The results are shown as median fluorescence intensity (MFI) and are representative of 2
independent experiments.
doi:10.1371/journal.ppat.1004058.g001
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ULBP1 and ULBP2 levels as early as 24 h p.i. (Fig. 1D, Fig. S1B,
Fig. S2). In contrast, deletion of UL142 (DUL142) had no overt
effect on the expression of any NKG2DL tested, including MICA
and ULBP3 (Fig. 1D, Fig. S1B, Fig. S2). Moreover, fibroblasts
infected with the high-passage HCMV laboratory strain AD169,
which lacks UL142 and several other genes, showed a level of
control of cell surface MICA (Fig. S3) comparable to that induced
by strain Merlin (Fig. 1D, Fig. S1B). The efficient control of MICA
expression in cells infected with strain AD169 and strain Merlin
DUL142 implied the existence of additional HCMV functions
capable of targeting MICA. We concluded that, although HCMV
activates MICA cell surface expression, this response is counter-
acted in the context of productive HCMV infection by the action
of a previously uncharacterized function.
US18–US22 is a major HCMV locus controlling cell surface
expression of MICA
HCMV contains 170 canonical protein-coding genes, of which
only 45 are essential for replication in fibroblast cells in vitro
[51,52,53]. In order to map HCMV functions to particular parts
of the genome, we generated 10 mutants in which blocks of non-
essential genes totaling 56 genes were deleted (Fig. S4A). To
facilitate detection of novel NK evasion functions, these mutants
were generated on a strain Merlin background that already lacked
UL16 and UL18 (DUL16DUL18) and contained a UL32-GFP
fusion reporter. Screening cells infected with these block deletion
mutants identified one mutant lacking US18–22 (DUS18–22),
which led to a marked increase in cell surface MICA detected by
flow cytometry (Fig. 2A). This mutant was also found to replicate
less efficiently than the parent virus (data not shown). Infection
with this mutant also resulted in a very marked increase in the total
cellular abundance of MICA/B (Fig. 2B). Specific antibodies to
other NKG2DLs were then used to see if this effect was specific by
flow cytometry. As the block deletion mutants were made on a
DUL16DUL18 background, the parental HCMV control up
regulated MICB and ULBP2 relative to mock-infected cells
(Fig. 2C, Fig. S4B), whereas the DUS18–22 mutant up regulated
cell surface levels of MICA (Fig. 2C, Fig. S4B) relative to both
mock- and parental HCMV-infections. These results suggest the
potential for an HCMV NK cell evasion function that acts by
promoting degradation of an NKG2DL.
US18 and US20 down-regulate MICA
To map the MICA-suppressing function more precisely, the 5
genes in the US18–US22 region were expressed individually in
fibroblasts using an Ad vector, and expression monitored by
detection of the V5 tag by intracellular flow cytometry (Fig. S5).
Expression of US18 or US20 led to reductions in MICA/B levels
by immunoblotting (Fig. 3A). Interestingly, expression of the
US18–US22 genes individually was each associated with a
marginal reduction in MICA cell surface expression; thus genes
adjacent to US18 and US20 could also be contributing to the
suppression of MICA (Fig. S6). In the context of an HCMV
infection, deletion of US18 and US20 led to an increase MICA/B
levels as monitored by immunoblotting (Fig. 3B). Deletion of both
US18 and US20 led to a further increase in MICA/B levels
(Fig. 3B). No differences in MICA/B glycosylation were observed
in cells infected with the different HCMV US18 and US20
deletion mutants when samples were treated with Endoglycosidase
H/EndoH (E) or Peptide N-Glycosidase F/PNGase F (P) (Fig. 3B).
Almost all of the MICA/B was EndoH-resistant and therefore
consistent with its localization in a post-ER compartment (e.g. cis-
Golgi, lysosomes, or cell surface expression).
By flow cytometry, deletion of US18 alone had no discernible
effect on cell surface expression of MICA, MICB, ULBP2 or
MHC-I (Fig. 3C, Fig. S7). In contrast, deletion of US20 induced a
modest but significant increase in surface levels of MICA
compared to parental virus, but MICB, ULBP2 and MHC-I
expression were unchanged. However, deletion of both US18 and
US20 caused a much more dramatic increase in MICA levels,
similar to that observed for US18–22 block deletion mutant
(Fig. 2C and 3C). These mutants had no appreciable difference in
replication efficiency (data not shown). Thus, absence of either
US18 or US20 was partially compensated by the other gene,
whereas absence of both genes had a more than additive effect on
MICA expression.
The HF cell lines (HF-TERT and HF-CAR) were immortalized
lines derived from the same donor HFs, which have a MICA
genotype, MICA*016/027 [54]. The same pattern of MICA cell
surface expression was obtaining using the primary parent HF cell
line infected with the US18 and US20 deletion mutants (data not
shown). To determine whether US18 and US20 could target a
range of MICA alleles, we performed a similar analysis in a
number of donor dermal fibroblast cell lines with different MICA
genotypes. These experiments revealed a greater dependence on
US20 for regulating MICA, as there was little (D43, MICA*007/
010) or no difference (D45, MICA*002/009 and NP, MICA*004/
004) between the single US20 deletion mutant and US18 and
US20 double deletion mutant (Fig. 3D, Fig. S8).
Analysis of US18 and US20 function in the context of
HCMV
To complement findings obtained with exogenous US18 and
US20 gene expression, the equivalent C-terminal V5 antigenic tag
was added to the genes in the context of the HCMV genome. In
contrast to transcriptomic studies [52], pUS18-V5 expression was
expressed at lower levels than pUS20-V5 at all stages of the
HCMV replication cycle, as gauged by the intensity of staining
from the V5 epitope tag (Fig. 4A). Therefore, functional
differences between the US18 and US20 single HCMV deletion
mutants (Fig. 3C) may reflect this difference in detectable
expression levels, or perhaps pUS18 is subject to a more rapid
cellular turnover than pUS20. However, comparable expression
between pUS18 and pUS20 was observed when using Ad vectors
(Fig. 4B). Analysis of pUS18 and pUS20 expression by immuno-
fluorescence staining in the context of HCMV revealed that both
proteins were located in subcellular punctate structures (Fig. 4C).
This pattern of expression was similar to that observed using the
US20 RAd (Fig. 4D), but contrasted with the ER-like expression
pattern detected for the US18 RAd (Fig. 4D). We concluded that,
whether expressed from Ads or in the context of HCMV, both
proteins reside within an intracellular compartment from which
they are able to regulate MICA expression.
HCMV targets MICA via US18 and US20 for lysosomal
degradation
Next, we sought to determine the fate of MICA in HCMV-
infected cells. Cells were infected with HCMV strain Merlin in
combination with chemical inhibitors of the major protein
degradation pathways that act via the proteasome (MG132) or
lysosome (folimycin) (Fig. 5A and B, Fig. S9A). Inhibition of
lysosomal, but not proteasomal, degradation greatly increased the
cellular levels of MICA/B as assessed by immunoblotting (Fig. 5A).
Addition of either MG132 or folimycin had no effect on cell surface
MICA or MICB expression in either mock or HCMV-infected cells
(Fig. 5B, Fig. S9A). Treatment with a further two lysosomal
HCMV Targets MICA for Lysosomal Degradation
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inhibitors, leupeptin (a protease inhibitor) and chloroquine (an
inhibitor of lysosomal acidification) led to an increase in MICA/B
levels by immunoblotting (Fig. 5C), but no effect on cell surface
MICA or MICB expression by flow cytometry (Fig. 5D, Fig. S9B).
Folimycin and chloroquine affect the acidification of the lysosomes
and the Golgi apparatus, while leupeptin is a protease inhibitor
targeting lysosomal proteases. Therefore, these inhibitors will
prevent degradation of proteins within the lysosome by preventing
the action of proteolytic enzymes requiring an acidic pH, but will
not redirect them from this compartment to the surface. Therefore
Figure 2. The HCMV gene function targeting MICA maps to the US18–22 gene locus. A. Fibroblasts (HF-TERTs) were mock infected or
infected with HCMV parent virus or a series of ‘block’ deletion mutants for 72 h. Cell surface expression of MICA was analyzed by immunostaining and
flow cytometry. Results shown are the median fluorescence intensity (MFI) and are representative of two independent experiments. B. Fibroblasts
(HF-TERTs) were mock infected or infected with HCMV parent virus or a deletion mutant lacking US18–22 (DUS18–22) for 72 h. Hydrophobic proteins
were extracted using Triton X-114 and protein expression analyzed by immunoblotting. Data shown is representative of three independent
experiments. C. Fibroblasts (HF-TERTs) were mock infected or infected with HCMV or a deletion mutant lacking US18–22 (DUS18–22) for 72 h. Cell
surface expression was analyzed by immunostaining and flow cytometry. Results shown are the median fluorescent intensity (MFI) and from three
independent experiments. The mean of the results was analysed by Student’s t-test (*P,0.05, **P,0.01, ***P,0.001).
doi:10.1371/journal.ppat.1004058.g002
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Figure 3. US18 and US20 down-regulate MICA levels. A. Fibroblasts (HF-CARs) were infected with recombinant adenovirus expressing the
individual US18–US22 genes for 72 h. Hydrophobic proteins were extracted using Triton X-114 and protein expression analyzed by immunoblotting.
Data shown is representative of four similar independent experiments. B. Fibroblasts (HF-TERTs) were mock infected or infected with HCMV, DUS18,
DUS20, DUS18&20 for 72 h. Hydrophobic proteins were extracted using Triton X-114, mock-treated (-) or treated with either Endoglycosidase H (E) or
PNGase F (P) and protein expression analyzed by immunoblotting. Results are representative of two independent experiments. C. Fibroblasts (HF-
TERTs) were mock infected or infected with HCMV, DUS18 or DUS18, DUS20 for 72 h. Cell surface expression was analyzed by immunostaining and
flow cytometry. Results shown are the median fluorescence intensity (MFI) and are from four independent experiments. The mean of the results was
analysed by Student’s t-test (*P,0.05, **P,0.01, ***P,0.001). D. Dermal fibroblasts expressing different MICA alleles were mock infected or infected
HCMV Targets MICA for Lysosomal Degradation
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HCMV appears to target MICA for lysosomal degradation, and this
protein is retained within the cell following lysosomal inhibition.
To examine further the effect of these genes on MICA, the
genes were delivered to a U373 cell line expressing a MICA-yellow
fluorescent protein (YFP) fusion protein (Fig. 6). MICA-YFP
expression was suppressed efficiently by US18 or US20, but could
be restored by treatment with the lysosomal inhibitor, folimycin
(Fig. 6). In the presence of folimycin, US18 expression caused
MICA-YFP to be redistributed to punctate intracytoplasmic
structures, in which MICA-YFP was co-localized with the US18
protein (pUS18; Fig. 6). Although US20 expression also induced
MICA-YFP to traffic to similar structures, the US20 protein
(pUS20) did not localize to this compartment (Fig. 6). Expression
of US19 as a control had no effect on MICA distribution (Fig. 6).
To investigate whether these intracellular structures represented
lysosomes, we performed similar experiments using a lysosomal
staining reagent (Lysotracker Red DND-99) (Fig. 7A). These
experiments showed that the MICA-YFP signal in both pUS18-
with HCMV, DUS18 or DUS18, DUS20 for 72 h. Cell surface expression was analyzed by immunostaining and flow cytometry. Results shown are the
median fluorescence intensity (MFI) and are from three independent experiments. The mean of the results was analysed by Student’s t-test (*P,0.05,
**P,0.01, ns = not significant).
doi:10.1371/journal.ppat.1004058.g003
Figure 4. Comparison of US18 and US20 expressed during HCMV infection and by adenovirus expression vectors. A. HF-TERTs were
either mock-infected or infected with HCMV wt or HCMV with V5-tagged US18 and US20 genes for 1, 3 or 5 days at an m.o.i. of 10. Cells were
harvested and hydrophobic proteins extracted with Triton-X114 before immunoblotting with an anti-V5, actin or UL141 antibodies. Results are
representative of two independent experiments. B. HF-CARs were infected with adenovirus control or expressing US18 or US20. Cells were harvested
and hydrophobic proteins extracted with Triton-X114 before immunoblotting with an anti-V5 and actin antibodies. Results are representative of five
independent experiments. C. HF-TERTs were either mock-infected or infected with HCMV wt or HCMV with V5-tagged US18 and US20 genes for 3
days at an m.o.i. of 10. Cells were fixed, permeabilized and immunostained with anti-V5 antibodies and anti-mouse Alexa Fluor-594 secondary
antibody, then counterstained with the nuclear stain DAPI and actin-binding phalloidin-Alexa Fluor 488. Results are representative of three
independent experiments. D. HF-CARs were infected with adenovirus control or expressing US18 or US20. Cells were fixed, permeabilized and
immunostained with anti-V5 antibodies and anti-mouse Alexa Fluor-594 secondary antibody, then counterstained with the nuclear stain DAPI and
actin-binding phalloidin-Alexa Fluor 488. Results are representative of six independent experiments.
doi:10.1371/journal.ppat.1004058.g004
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and pUS20-expressing cells treated with folimycin co-localized
with the lysosomal staining. The pUS18 staining was also
lysosomal, whereas that of pUS20 was not. We also investigated
whether pUS18 and pUS20 co-localized with the lysosomes in the
context of HCMV infection (Fig. 7B). This analysis did not clearly
reveal an association of pUS18 and pUS20 staining with that of
lysosomes, although there was some co-localization in a proportion
of cells with a strong cytopathic effect. In many cells, pUS20
appeared to be present in an intracellular compartment adjacent
to the lysosomal staining. We concluded that both proteins
promote proteolysis of MICA in the lysosome.
US18 and US20 both encode NK cell evasion functions
Before designating a virus gene as being an NK cell evasion
function, it is important to monitor its biological activity during
infection. The effects of US18 and US20 on NK cell recognition
were therefore analyzed using the HCMV deletion mutants
described above (Fig. 8A, Fig. S10). Relative to uninfected cells,
infection with strain Merlin elicited robust protection against NK
cells in all donors tested. A significant increase in NK cell
degranulation was associated with loss of US18 or US20 (Fig. 8A)
or the US18–22 ‘block’ deletion (Fig. S10B), and an additive effect
was observed when both genes were absent. We concluded that
US18 and US20 are effective in suppressing NK cell activation in
the context of a productive HCMV infection. The use of a MICA
blocking antibody led to a small decrease in NK degranulation in
response to targets infected with the US18 and US20 double
deletion virus, whilst the same antibody had no effect on NK
activation in response to Mock or HCMV-infected targets
(Fig. 8B). These data suggest that either the blockade of MICA
was incomplete or that US18 and US20 target other cellular
molecules capable of regulating NK cell activation.
Discussion
HCMV-infected fibroblasts are extraordinarily resistant to NK
cells as assessed in vitro by cytolysis or CD107-mobilization assays
Figure 5. Effect of proteasomal and lysosomal inhibitors on MICA/B degradation by HCMV. A. Fibroblasts (HF-TERTs) were mock-infected
or infected with HCMV for 72 h. A proteasomal inhibitor (MG132) or lysososomal inhibitor (folimycin) was added 12 h prior to harvesting.
Hydrophobic proteins were extracted using Triton X-114, and protein expression was analyzed by immunoblotting. The results are representative of 3
independent experiments. B. Fibroblasts (HF-TERTs) were either mock infected or infected with HCMV for 72 h. A proteasomal inhibitor (MG132) or
lysososomal inhibitor (folimycin) was added 12 h prior to harvesting. Cell surface expression was analyzed by immunostaining and flow cytometry.
The results shown are the median fluorescent intensity (MFI) and are representative of 3 independent experiments. C. Fibroblasts (HF-TERTs) were
mock-infected or infected with HCMV for 72 h. The lysosomal inhibitors leupeptin or chloroquine were added 12 h prior to harvesting. Hydrophobic
proteins were extracted using Triton X-114, and protein expression was analyzed by immunoblotting. The results are representative of 2 independent
experiments. D. Fibroblasts (HF-TERTs) were either mock infected or infected with HCMV for 72 h. The lysosomal inhibitors leupeptin or chloroquine
were added 12 h prior to harvesting. Cell surface expression was analyzed by immunostaining and flow cytometry. The results shown are the median
fluorescent intensity (MFI) and are representative of 2 independent experiments.
doi:10.1371/journal.ppat.1004058.g005
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Figure 6. Degradation of MICA-YFP by US18 and US20 in U373 cells. U373 cells stably transfected with MICA-YFP were infected with control
or US18-V5, US19-V5 or US20-V5 expressing adenovirus for 72 h in duplicate. Folimycin was added to one duplicate well 12 h prior to analysis. Cells
were fixed and permeabilized and immunostained with a mouse antibody for the V5 epitope tag plus anti-mouse IgG-Alexa Fluor 594 secondary
antibody and counterstained with the nuclear dye DAPI. Results are representative of three similar independent experiments.
doi:10.1371/journal.ppat.1004058.g006
HCMV Targets MICA for Lysosomal Degradation
PLOS Pathogens | www.plospathogens.org 9 May 2014 | Volume 10 | Issue 5 | e1004058
[29,30]. Nonetheless, NK cells play a critical role in combating
infections in vivo. We set out to determine whether the rapid up
regulation of NKG2DL transcription driven by expression of the
major HCMV IE genes would result in transient exposure of the
activating ligands MICA, MICB, or ULBP2 early during infection
[44,45], thereby creating a window of opportunity for NK cell
recognition. These studies revealed an interesting differential
effect; HCMV IE1 preferentially unregulated the NKG2DL
ULBP2, whereas IE2 predominantly activated MICA/B. Al-
though IE1 and IE2 are encoded from within the same
transcriptional unit by differential splicing, they are functionally
distinct. IE1 is not essential for viral replication, but enhances
replication by targeting intrinsic barriers to viral infection (PML-
bodies, hDaxx, STAT-2, and p107), whereas IE2 is essential and is
a potent transcriptional transactivator [55]. It is logical that
individual NKG2DL should be differentially sensitive to specific
triggers of cellular stress. Indeed, the dichotomy presented by the
major HCMV IE genes provides a tractable experimental system
by which to explore the cellular mechanisms that underpin
NKG2DL regulation. Despite their up regulation by IE genes,
HCMV was observed to suppress NKG2DL expression efficiently
right through the early and late phases of the replication cycle.
Activation of NKG2DL expression during infection could only
be detected when the viral genome had been engineered to delete
relevant NK cell evasion functions; studies using such deletion
mutants elegantly reveal the relative contributions made by
individual NK cell evasion genes in mounting a comprehensive
defense. While the control of MICB, ULBP1 and ULBP2 by
UL16 was fully consistent with previous findings [46], unexpect-
edly the UL142 deletion mutant had no overt effect on MICA or
ULBP3 expression. Strain AD169 controlled MICA expression
despite containing a 15 kbp deletion that includes UL142 (this
study; [56]). These observations prompted us to search for
additional HCMV functions capable of targeting MICA, which
were mapped to US18 and US20 using a combination of HCMV
‘block’ deletion mutants on a DUL16,DUL18,UL32-GFP back-
Figure 7. Targeting of MICA-YFP within lysosomes. A. U373 cells stably transfected with MICA-YFP were infected with US18- or US20
expressing adenovirus for 72 h. Folimycin was added 12 h prior to analysis. Cells were incubated with Lysotracker Red DND-99 (1:1000) for 30 mins,
washed once in DMEM and twice in PBS, fixed and permeabilized, and immunostained with a mouse antibody for the V5 epitope tag plus anti-mouse
IgG-Alexa Fluor 350 secondary antibody. Results are representative of two independent experiments. B. HF-TERTs were infected with US18-V5 tagged
HCMV or US20 V5-tagged HCMV for 72 hr. Leupeptin was added 12 h prior to analysis. Cells were incubated with Lysotracker Red DND-99 (1:1000) for
30 mins, washed once in DMEM and twice in PBS, fixed and permeabilized, and immunostained with a rabbit antibody for the V5 epitope tag plus
anti-rabbit IgG-Alexa Fluor 488 secondary antibody and counterstained with the nuclear dye DAPI. Results are representative of two independent
experiments.
doi:10.1371/journal.ppat.1004058.g007
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ground and adenovirus vectors expressing individual HCMV
genes. Human viruses are known to eliminate host proteins
selectively by recruiting cellular proteasomal or lysosomal proteo-
lytic pathways. A specific role for the lysosome in the proteolytic
degradation of MICA in HCMV-infected cells was identified.
The functions of US18 and US20 were validated in the context
of HCMV productive infection. Deletion of US18 and US20
individually was associated with either no effect or a modest but
significant increase in MICA cell surface expression relative to
HCMV-infected cells, and both of these deletions enhanced NK
cell activation in a functional assay. pUS18 and pUS20 are thus
able individually to compensate for each other’s loss in regulating
MICA. Deletion of both genes together reduced the efficiency of
MICA down regulation in a more than additive fashion, and yet
consistently resulted in only a modest increase in NK cell
activation above that observed for the single US18 and US20
deletions. One possible explanation of this is that the MICA
antibodies used may not recognize all glycosylated isoforms of
MICA with equal efficiency. Also, NK cells are controlled by
thresholds, and thus cannot be expected to respond with linear
kinetics to levels of MICA expression.
Neither US18 nor US20 has been assigned a function
previously. However, both genes belong to the HCMV US12
family, which consists of ten tandemly arranged genes (US12–
US21) encoding distantly related seven-transmembrane domain
proteins [46]. A low level of amino acid sequence similarity has
been noted between some US12 gene family members and the
transmembrane BAX-inhibitor motif containing protein (TMBIM)
superfamily [57,58,59]. The 6 TMBIM family proteins
(TMBIM1–6) have functions relating to apoptosis and regulation
of ER stress [60], and TMBIM6 (BAX-inhibitor 1) regulates
lysosomal degradation of Gb3 and P450 2E1 [61,62]. Although a
poxvirus-encoded TMBIM4 homolog (viral GAAP, Golgi anti-
apoptotic protein) has been shown to suppress apoptosis [63], no
such function has yet been assigned to any US12 family member.
The significance, if any, of the similarity of US12 family proteins
to TMBIM family proteins in evolutionary and functional terms
remains unknown. The same evaluation applies to the more
marginal similarities to G protein-coupled receptors [53].
The HCMV genome contains 15 families of related genes, each
potentially acquired via a process of gene duplication [51,64]. The
US12 family may have arisen as a genomic ‘‘accordion’’, which
involves the rapid expansion of a single gene under a strong selective
pressure, to an array of related genes, which may collapse
subsequently if the selective pressure wanes. This feature was
recently demonstrated experimentally in a poxvirus (vaccinia virus)
to facilitate selective adaption to the host’s intrinsic antiviral
defences [65]. Expansion of the US12 family is likely to have long
pre-dated the speciation of humans, as the family is well conserved
in cytomegaloviruses of chimpanzee and Old World primates
(Rhesus and Cynomolgus macaques), which encode the same
genomic arrangement of 10 recognizable US12 family genes.
Several US12-related genes are also present in cytomegaloviruses of
New World primates (Green Monkey and Owl Monkey), although
these vary in number (11 and 7 genes respectively)
[49,51,66,67,68,69]. In support of a genomic accordion expansion,
the ten US12 family members (US12–US21) are encoded tandemly
in a gene cluster that is transcribed in three transcriptional cassettes:
US12–US17, US18–US20, and US21 independently [70,71,72].
The presence of the US12 family in primate cytomegalovirus
genomes implies that the selective pressure that initially induced
the expansion has been maintained in some form, and the various
numbers and arrangements of US12-related genes indicates that
the family has continued to adapt and diverge in order to acquire
an expanded functional range. Interestingly, the US6 gene family
(US6–US11) contains multiple members (US6, US10, and US11)
that target the MHC-I antigen-processing pathway, with the
individual proteins targeting various parts of the pathway in order
to provide greater effectiveness and resistance to mechanisms of
host resistance [13,14,73,74]. In this context, it is interesting to
note that efficient down regulation of MICA requires both US18
and US20. Further functional studies may provide additional
insights into the evolution and functions of the US12 family.
US18 and US20 now join with UL16, UL142 and miR-UL112
in expanding to five the set of HCMV genes that have been
demonstrated to counter the action of the single NK cell activating
receptor, NKG2D. In addition to its role in regulating the function
of NK cells, NKG2D is also expressed ubiquitously on cd-T cells
and a subset of ab-T cells. The number of HCMV-encoded gene
products targeting the NKG2D pathway emphasizes the impor-
tance of this activating receptor in the immune response to HCMV.
Materials and Methods
Ethics statement
Healthy adult volunteers provided blood and dermal fibroblasts
for this study following written informed consent (approved by the
Cardiff University School of Medicine Ethics Committee Ref. no:
10/20).
Cell lines
Human fetal foreskin fibroblasts immortalized by human
telomerase (HF-TERT), HF-TERTs transfected with the Cox-
sackie-adenovirus receptor (HF-CAR), donor dermal fibroblasts
(primary and TERT-immortalized), and U373 MICA-YFP-
expressing cells (were maintained at 37uC in 5% CO2 in growth
medium (Dulbecco’s minimal essential medium (DMEM) supple-
mented with penicillin/streptomycin and 10% fetal calf serum
(Invitrogen, Paisley, UK)) [75]. U373-MICA-YFP cells were
constructed by transfecting full-length MICA allele (Genbank
Accession no. AAD52060) fused to YFP, (a gift from Professor
Dan Davis, University of Manchester, UK, generated as
previously described [76]) into U373 cells with Effectene (Qiagen,
Manchester, UK) and adding drug selection using 0.75 mg/ml
G418 (Invitrogen).
MICA typing
DNA was extracted from donor blood samples using the Qiagen
Blood and tissue DNA extraction kit. MICA typing was performed
by the Anthony Nolan Trust, as previously described [54].
Figure 8. Loss of US18 and US20 increases NK degranulation in response to HCMV-infected targets. A. Fibroblasts (HF-TERTs) were
mock infected or infected with the Merlin strain of HCMV or mutants lacking US18 (DUS18), US20 (DUS20) or combination of US18 and US20 (DUS18,
DUS20) for 72 h. Infected cells were incubated with donor PBMC for 5 h and NK degranulation assessed by % CD107+ cells within the CD32, CD56+
population by flow cytometry. Results are shown from 3 separate donors performed in triplicate and the mean of pooled results was analysed by
Student’s t-test (*P,0.05, **P,0.01, ***P,0.001). B. HF-TERTs were mock infected or infected with the Merlin strain of HCMV or the US18 and US20
deletion mutant for 72 h. Infected cells were incubated with isotype control or a MICA blocking antibody for 30 min prior to incubation with donor
PBMC for 5 h. NK degranulation was assessed by % CD107+ cells within the CD32, CD56+ population by flow cytometry. Results are shown from 2
separate donors performed in triplicate and the results were analysed by Student’s t-test (**P,0.01, ***P,0.001, ns = not significant).
doi:10.1371/journal.ppat.1004058.g008
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Viruses
HCMV deletion mutants were generated by recombineering of
the bacterial artificial chromosome (BAC) of HCMV strain Merlin
(GenBank accession number GU179001.1), as described previ-
ously [77]. Strain Merlin contains the complete genetic comple-
ment of HCMV, and is frame shifted in two genes (RL132,
UL1282). The regions encompassing the sites recombineered in
BACs were verified by PCR and sequencing. A list of HCMV
constructs, indicating deleted genes, other modifications, and the
primers used in their production, is shown in Text S1. The
HCMV strain AD169 (varUK; Genbank accession number
BK000394) previously described was also used in some experi-
ments [78,79]. Recombinant adenoviruses (RAds) were generated
as described previously [80]. Briefly, HCMV genes were amplified
from the strain Merlin BAC by using primers containing arms of
homology to the adenovirus BAC vector (pAL1141) and
recombineered into pAL1141. RAd-IE1 and IE2 contained IE1
and IE2 from HCMV strain AD169 cloned into the adenovirus
BAC vectors. A list of RAds used and the primers used to generate
them is shown in Text S2.
Viral infections
Cells were seeded in growth medium at appropriate cell
densities (16106 cells for a 25 cm2 flask, 56105 cells per well for
a 6-well plate, 56104 cells per well for a 24-well plate). The
following day, the cells were infected with virus at the required
multiplicity of infection in an appropriate volume of growth
medium (2 ml for a 25 cm2 flask, 1 ml per well for a 6-well plate,
250 ml per well for a 24-well plate) for 2 h on a rocker at 37uC in
5% CO2. The inoculum was then replaced with fresh growth
medium (7 ml for a 25 cm2 flask, 4 ml per well for a 6-well plate,
1 ml per well for a 24-well plates), and the cells were incubated for
the required times. Fetal calf serum was omitted from the growth
medium for HCMV infections. For inhibitor studies, cells were
treated 12 h prior to harvesting with proteasomal (MG132 10 mM)
or lysosomal inhibitors (folimycin 1 mM, leupeptin 200 mM or
chloroquine 100 mM) in DMEM.
Flow cytometric analysis of cell surface marker
expression
Cells were harvested by washing once with phosphate-buffered
saline (PBS) and treating with 16 trypsin/EDTA for 1 min at
37uC. After neutralizing the trypsin with growth medium, the cells
were washed once in flow cytometry (FC) buffer (1% bovine serum
albumin and 0.05% sodium azide in PBS). The cells were
resuspended in an unconjugated primary antibody (murine IgG,
Sigma Aldrich, Poole, UK, 1:1000 dilution in FC buffer; anti-
MICA clone AM01, anti-MICB clone BM02, anti-MICA/B clone
BAM01, anti-ULBP2 clone BUM01, BAMOMAB GmBH,
Graefelfing, Germany, 1:400 dilutions in FC buffer; anti-ULBP1
Clone 170818, MAB1380, anti-ULBP3 Clone 166510, MAB1517,
R&D Systems, Abingdon, UK, 1:200 dilutions in FC buffer; anti-
MHC-I, clone W632, AbD Serotec, Kidlington, UK, 1:2000
dilution in FC buffer) and incubated for 30 min at 4uC. The cells
were then washed twice with FC buffer and incubated in an Alexa
Fluor 647 conjugated anti-mouse IgG secondary antibody
(Invitrogen, 1:500 dilution in FC buffer) for 30 min at 4uC. After
3 further washes in FC buffer, the cells were fixed in 2%
paraformaldehyde (PFA) for 10 min and analyzed by using an
Accuri Cflow cytometer (BD Biosciences, Oxford, UK). A forward
scatter and side scatter dot plot was used to gate both on viable
cells and infected cells (Fig. S1A). The median fluorescence
intensity (MFI) was used in subsequent analysis.
Triton X-114 extraction of membrane proteins
Cells were washed once with ice-cold PBS, scraped into 4 ml
ice-cold PBS, recovered by centrifugation (1,600 rpm for 3 min),
and stored at 220uC. They were then resuspended in 300 ml
Triton X-114 extraction buffer (2% Triton X-114, 1:100 protease
inhibitors, and 1 mM DTT in PBS) and sonicated. The lysate was
clarified by microcentrifugation at 13,000 rpm for 1 h at 4uC in a
1.5 ml non-stick tube. The supernatant was transferred to a fresh
1.5 ml non-stick tube, incubated at 37uC for 10 min, and
microcentrifuged at 13,000 rpm for 5 min at 37uC. The upper
phase was removed, leaving a bead of Triton-X114 of approxi-
mately 60 ml. PBS was added up to a total volume of 300 ml and
the samples sonicated. The extracted protein was precipitated by
adding 1.2 ml precipitation reagent (Merck protein precipitation
kit 539180) and incubating at 220uC for 1 h, and collected by
centrifuging at 13,000 rpm for 10 min at 4uC and aspirating the
supernatant. The precipitated proteins were washed once with
500 ml wash buffer (Merck protein precipitation kit 539180) and
collected by centrifuging at 13,000 rpm for 10 min at room
temperature and aspirating the supernatant. The pellets were
allowed to air dry for a few minutes and then resuspended either in
16Nupage gel sample buffer (Invitrogen) plus 10 mM DTT for
direct immunoblotting or in 16 denaturing buffer (NEB) for
EndoH and PNGase F treatment. Samples were denatured at
95uC for 10 mins or for analysis of US18 and US20 expression at
50uC for 10 mins. Denaturation at 95uC was found to lead to high
molecular weight smears of US18 and US20 in resulting
immunoblots, presumably due to formation of aggregates as noted
for other polytopic membrane proteins.
Immunoblotting
Protein samples (20 ml) were separated on ready-made 10% Nu-
PAGE polyacrylamide gels (Invitrogen) by SDS-PAGE and
transferred to Hybond-P nitrocellulose (GE Life Science) by
semi-dry blotting. Nitrocellulose membranes were prepared by
treating with 5 ml Pierce MISER antibody extender (Fisher
Scientific) for 10 min and washing 7 times with distilled water.
They were then blocked in 5% milk in Tris-buffered saline
containing 0.05% TWEEN-20 and 0.05% Triton X-100 (TBS-T-
T) overnight at 4uC. The membranes were then incubated with
primary antibodies diluted in 5% milk in TBS-T-T overnight at
4uC. They were then washed 5 times for 5 min in TBS-T-T, and
incubated in anti-mouse IgG-HRP conjugate (Insight Biotechnol-
ogy Ltd, Wembley, UK, 1:5,000–1:10,000) for 1 h at room
temperature. After washing a further 5 times for 5 min in TBS-T-
T, the membranes were incubated for 5 min in SuperSignal West
Pico Chemiluminescent substrate (Fisher Scientific) before being
exposed to Hyperfilm-MP film (GE Life Science, Little Chalfont,
UK) for development. The blots were stripped in Pierce Stripper
buffer (Fisher Scientific) for 10 min, washed 7 times in TBS-T-T,
reblocked, and reprobed.
Immunofluorescence staining and analysis
Cells were grown and infected with virus in glass-bottomed 24-
well plates. At various times p.i., the cells were washed with PBS,
and fixed with 2% PFA for 10 min. In some instances, cells were
incubated with LysoTracker Red DND-99 (Cat. no. L7528,
1:1000 in complete DMEM, Invitrogen) for 30 min, washed once
with complete DMEM, then PBS and and fixed with 2% PFA for
10 min. The fixed cells were washed twice with IC buffer (0.2%
saponin, 1% BSA, 0.05% sodium azide in PBS) and incubated
with primary antibodies (anti V5-tag, AbD Serotec) diluted in IC
buffer for 1 h at 4uC. The cells were then washed 3 times with IC
buffer and incubated with Alexa Fluor 594 or 350 (Lysotracker
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experiments)-conjugated anti-mouse IgG antibodies (Invitrogen)
for 1 h at 4uC. The cells were washed once with IC buffer and
where required incubated for 10 min with DAPI (0.5 mg/ml)
diluted in IC buffer. They were then washed twice further in IC
buffer, before the addition of 2% PFA and analysis by fluorescent
microscopy.
Intracellular flow cytometry
Cells were harvested by washing once with phosphate-buffered
saline (PBS) and treating with 16 trypsin/EDTA for 1 min at
37uC. After neutralizing the trypsin with growth medium, the cells
were washed with PBS and fixed with 2% PFA for 10 mins. The
fixed cells were washed twice with IC buffer and incubated with
anti-V5 tag antibody (1:2000) or control mouse IgG diluted in IC
buffer for 1 hr at 4uC. The cells were washed twice with IC buffer
and incubated with Alexa Fluor 647-conjugated anti-mouse IgG
antibodies (1:500) for 30 mins at 4uC. They were then washed
three times in IC buffer, before the addition of 2% PFA and
analysis by flow cytometry.
NK cytotoxicity assays
NK cytotoxicity was assessed by standard 51Cr chromium
release assay as described previously [39], using labelled RAd-
infected fibroblast target cells. The effector:target (E:T) ratio was
adjusted by using the number of NK cells present in the CD3+-
depleted IFN-a-activated peripheral blood mononuclear cells
(PBMC) used as effectors. Specific lysis (%) was calculated as
[(experimental mean release - spontaneous mean release)/(max-
imum mean release - spontaneous mean release)]6100. The mean
and SEM were determined from the results of triplicate or
quadruplicate samples.
NK degranulation assays
NK degranulation assays were performed in a similar manner to
that described previously [39,81]. Briefly, PBMC (approved by the
Cardiff University School of Medicine Ethics Committee Ref. no:
10/20) and incubated overnight with IFN-a (1000 IU/ml) and IL-
15 (15 ng/ml, Milenyi Biotech). PBMC (0.5–16106) were
incubated for 6 h with 0.5–16105 fibroblast targets per well in a
96 well plate at an effector:target (E:T) ratio of 10:1, with the
addition of 3 ml per well FITC-conjugated anti-CD107 antibody
(cat. no. 555800, clone H4A3, BD Biosciences) or 3 ml per well
FITC-conjugated isotype control (cat. no. 555748, BD Bioscienc-
es), adding 1 ml/well BD GolgiStop (BD Biosciences) 1 h after
beginning the incubation. (For antibody blocking experiments,
targets were pre-incubated with anti-MICA (Clone 159277, mouse
IgG2B, MAB1300, R&D Systems) or isotype control (MICB non-
blocking antibody, Clone 236511, mouse IgG2B, MAB1599,
R&D Systems) antibodies at a concentration of 10 mg/ml for
30 min prior to incubation with PBMC). PBMC were harvested
and stained with conjugated antibodies against CD3 (anti-CD3
PE-Cy7, cat. no. 737657, Beckman Coulter, High Wycombe, UK)
and CD56 (anti-CD56 PE, cat. no. A07788, Beckman Coulter),
and fixed in 2% PFA before analysis by flow cytometry (BD
Biosciences Accuri C Flow) (Fig. S10A).
Supporting Information
Figure S1 Regulation of NKG2DL expression during
HCMV infection. A. Fibroblasts (HF-TERTs) were mock-
infected or infected with HCMV strain Merlin or deletion mutants
of this strain lacking UL16 (DUL16) or UL142 (DUL142).
Representative flow cytometry plots show the FSC/SSC gating
strategy applied to gate on mock- and HCMV-infected cells. B.
Fibroblasts (HF-TERTs) were mock-infected or infected with
HCMV strain Merlin or deletion mutants of this strain lacking
UL16 (DUL16) or UL142 (DUL142). Cell surface expression of
MICA, MICB, MICA/B, ULBP2, MHC-I, or murine immuno-
globulin (mIgG) was analyzed between 6 and 120 h p.i. by flow
cytometry. Flow cytometry plots representative of two indepen-
dent experiments are shown.
(TIFF)
Figure S2 Regulation of ULBP1 and ULBP3 expression
by HCMV expression. A. Fibroblasts (HF-TERTs) were mock-
infected or infected with HCMV strain Merlin or deletion mutants
of this strain lacking UL16 (DUL16) or UL142 (DUL142). Cell
surface expression of ULBP1, ULBP3, MHC-I, or murine
immunoglobulin (mIgG) was analyzed between 6 and 120 h p.i.
by flow cytometry. The results are shown as median fluorescence
intensity (MFI) and are representative of 2 independent experi-
ments. There was a small increase in ULBP3 on DUL16-infected
cells. B. Flow cytometry plots representative of two independent
experiments are shown.
(TIFF)
Figure S3 HCMV strain AD169 down regulates MICA. A.
HF-TERTs were infected with HCMV strain AD169 at an m.o.i.
of 10 for 72 h and MICA, MICB, MICA/B, ULBP2, and MHC-I
expression were assessed by flow cytometry relative to a murine
immunoglobulin (mIgG) control. The results are shown from three
independent experiments. B. HF-TERTs were infected with
HCMV strain AD169 at an m.o.i. of 10 for 72 h and MICA,
MICB, MICA/B, ULBP2, and MHC-I expression were assessed
by flow cytometry relative to a murine immunoglobulin (mIgG)
control. Flow cytometry plots representative of 3 independent
experiments are shown.
(TIFF)
Figure S4 Regulation of NKG2DL by HCMV ‘block’
deletion mutants. A. A schematic indicating the 10 HCMV
‘block’ deletions on the HCMV Merlin genome is shown. B.
Fibroblasts (HF-TERTs) were mock infected or infected with
HCMV or a deletion mutant lacking US18–22 (DUS18–22) for
72 h. Cell surface expression was analyzed by immunostaining
and flow cytometry. Flow cytometry plots representative of 3
independent experiments are shown.
(TIFF)
Figure S5 Detection of US18–22 V5 expression by
intracellular flow cytometry. Fibroblasts (HF-CARs) were
infected with recombinant adenovirus expressing the individual
US18–US22 genes for 72 h. V5 expression was analyzed by
immunostaining with anti-V5 antibody or control mIgG and anti-
mouse AF647 –conjugated secondary, followed by flow cytometry.
Results are representative of three independent experiments.
(TIFF)
Figure S6 Effect of US18–US22 expression in HF-CAR on
cell surface expression of MICA. Fibroblasts (HF-CARs)
were infected with recombinant adenovirus expressing the
individual US18–US22 genes for 72 h. MICA expression was
analyzed by immunostaining with a MICA-specific antibody and
anti-mouse AF647 conjugated secondary, followed by flow
cytometry. A. The median fluorescence intensity (MFI) values
from three independent experiments are shown. B. Representative
flow cytometry plots are shown.
(TIFF)
Figure S7 Analysis of MICA cell surface expression in
cells infected with HCMV US18 and US20 deletion
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mutants. A. Fibroblasts (HF-TERTs) were mock infected or
infected with HCMV, DUS18 or DUS18, DUS20. Cell surface
expression was analyzed by immunostaining and flow cytometry
between 6 and 120 h p.i. Results shown are representative of two
independent experiments. B. Fibroblasts (HF-TERTs) were mock
infected or infected with HCMV, DUS18 or DUS18, DUS20 for
72 h. Cell surface expression was analyzed by immunostaining
and flow cytometry. Flow cytometry plots representative of four
independent experiments are shown.
(TIFF)
Figure S8 Effect of US18 and US20 on different MICA
alleles. Dermal fibroblasts expressing different MICA alleles
were mock infected or infected with HCMV, DUS18 or DUS18,
DUS20 for 72 h. Cell surface expression was analyzed by
immunostaining and flow cytometry. Flow cytometry plots are
representative of three independent experiments.
(TIFF)
Figure S9 Effect of proteasomal and lysosomal inhibi-
tors on cell surface MICA/B expression in HCMV
infection. A. Fibroblasts (HF-TERTs) were mock-infected or
infected with HCMV for 72 h. A proteasomal inhibitor (MG132)
or lysososomal inhibitor (folimycin) was added 12 h prior to
harvesting. Cell surface expression was analyzed by immunostain-
ing and flow cytometry. The flow cytometry plots shown are
representative of 3 independent experiments. B. Fibroblasts (HF-
TERTs) were mock-infected or infected with HCMV for 72 h.
The lysosomal inhibitors leupeptin or chloroquine were added
12 h prior to harvesting. Cell surface expression was analyzed by
immunostaining and flow cytometry. The flow cytometry plots are
representative of 2 independent experiments.
(TIFF)
Figure S10 Analysis of NK cell activation by CD107
mobilization. A. Representative flow cytometry plots show the
gating strategy used for the CD107 mobilzation assays. Viable
PBMCs were gated initially on a FSC/SSC gate and then the
CD32 (PE-Cy7/FL4), CD56+ (PE/FL2) population was gated to
allow analysis of CD107 staining (FITC/FL1). B. Mock-infected
cells or cells infected with HCMV, parent (UL162, UL182,
UL32-GFP), or DUS18–22 (UL162, UL182, US18–222, UL32-
GFP) virus for 72 hrs were used as targets in a CD107
mobilszation assay using blood bag-derived PBMC.
(TIFF)
Text S1 HCMV constructs utilized and primers used in
their generation. A table shows the relevant HCMV viruses as
they are referred to in the text, an internal (lab.) BAC reference
and any genetic modifications they contain relative to the clinical
HCMV Merlin strain. Primer sequences used in their generation
are listed, which were used either to target selection cassettes or
delete/insert sequences during recombineering reactions or for
subsequent sequencing.
(DOCX)
Text S2 Adenovirus constructs utilized and primers
used in their generation. A table shows the relevant
Adenovirus constructs as they are referred to in the text, an
internal (lab.) BAC reference and the gene insert. Primer
sequences used in their generation are listed, which were used
either to insert the gene sequence during recombineering reactions
or for subsequent sequencing.
(DOCX)
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